CCDC93 inhibitors are a class of chemical compounds designed to specifically target and inhibit the activity of CCDC93, a protein involved in cellular processes such as membrane trafficking and endosomal transport. CCDC93 is a coiled-coil domain-containing protein, a structural motif that facilitates protein-protein interactions and contributes to the organization of cellular machinery. This protein is part of a larger complex, often functioning alongside other proteins to mediate the sorting and transport of vesicles between different compartments within the cell, such as the endoplasmic reticulum, Golgi apparatus, and endosomes. Inhibiting CCDC93 disrupts these interactions and impairs vesicular transport, leading to alterations in cellular homeostasis and protein trafficking.
The mechanism by which CCDC93 inhibitors function typically involves binding to the coiled-coil domain or another critical region of the protein, preventing it from interacting with its binding partners and effectively dismantling the protein complexes necessary for proper vesicle transport. By inhibiting CCDC93, these compounds interfere with the cellular logistics of moving proteins and lipids to their intended destinations. Researchers use CCDC93 inhibitors to study the intricacies of intracellular transport and to better understand the role of CCDC93 in coordinating the dynamic processes of vesicle formation, movement, and sorting. These inhibitors provide valuable insights into how defects in membrane trafficking can affect cellular function and highlight the importance of proteins like CCDC93 in maintaining the organization and flow of materials within the cell.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
Bafilomycin A1 | 88899-55-2 | sc-201550 sc-201550A sc-201550B sc-201550C | 100 µg 1 mg 5 mg 10 mg | $96.00 $250.00 $750.00 $1428.00 | 280 | |
Inhibits the vacuolar-type H+-ATPase (V-ATPase), disrupting endosomal acidification, which can affect CCDC93 function in trafficking. | ||||||
Dynamin Inhibitor I, Dynasore | 304448-55-3 | sc-202592 | 10 mg | $87.00 | 44 | |
Inhibits dynamin, affecting vesicle scission from the plasma membrane, which can alter endosomal input and CCDC93 activity. | ||||||
Monensin A | 17090-79-8 | sc-362032 sc-362032A | 5 mg 25 mg | $152.00 $515.00 | ||
Ionophore that disrupts Golgi function, impacting trafficking pathways that can intersect with CCDC93's role. | ||||||
Pitstop 2 | 1419093-54-1 | sc-507418 | 10 mg | $360.00 | ||
Inhibits clathrin-mediated endocytosis, potentially altering the trafficking routes that CCDC93 is involved in. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $26.00 $92.00 $120.00 $310.00 $500.00 $908.00 $1821.00 | 46 | |
Tyrosine kinase inhibitor that can affect signaling pathways and thereby indirectly modify CCDC93-related trafficking. | ||||||
Chlorpromazine | 50-53-3 | sc-357313 sc-357313A | 5 g 25 g | $60.00 $108.00 | 21 | |
Blocks clathrin-mediated endocytosis, which can impact the endosomal sorting processes involving CCDC93. | ||||||
Ikarugamycin | 36531-78-9 | sc-202179 | 500 µg | $185.00 | 4 | |
Inhibits clathrin-mediated endocytosis, potentially affecting the endosomal route and CCDC93's role. | ||||||
5-(N-Ethyl-N-isopropyl)-Amiloride | 1154-25-2 | sc-202458 | 5 mg | $102.00 | 20 | |
Inhibits macropinocytosis, which could change the endocytic trafficking that CCDC93 may regulate. | ||||||
Filipin III | 480-49-9 | sc-205323 sc-205323A | 500 µg 1 mg | $116.00 $145.00 | 26 | |
Binds to cholesterol, disrupting lipid rafts and possibly influencing endosomal sorting and CCDC93's activity. | ||||||
Nocodazole | 31430-18-9 | sc-3518B sc-3518 sc-3518C sc-3518A | 5 mg 10 mg 25 mg 50 mg | $58.00 $83.00 $140.00 $242.00 | 38 | |
Destabilizes microtubules, affecting intracellular transport systems that are essential for CCDC93's trafficking role. |